Teleflex Incorporated: Business Overview, Financials & Competitive Analysis
Teleflex Incorporated scores 5/10 on the AskCyborg Cyborg Score (Mixed). Mid-cycle transformation story with significant execution risks amid recent leadership change and demand softness, offset by strategic focus on higher-growth vascular and interventional segments. In early January 2026, Teleflex announced leadership changes and lowered its preliminary 2025 revenue guidance to about US$3.27 billion due to softer demand and order delays.
What is Teleflex Incorporated's industry? Teleflex Incorporated (teleflex.com) operates in Medical Devices - Surgical & Critical Care. AskCyborg classifies Teleflex Incorporated under Medical Devices - Surgical & Critical Care in its company registry.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (...
Cyborg Score thesis
Mid-cycle transformation story with significant execution risks amid recent leadership change and demand softness, offset by...
Read the full analyst-debate transcript →Get the Latest Teleflex Incorporated Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeTeleflex Incorporated Overview
Pro stress-test →Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%).
Strategic Profile
Pro stress-test →With the announced sale of its Acute Care, Interventional Urology and OEM businesses, Teleflex is entering its next phase as a more focused, higher-growth organization. The acquisition and integration of the Vascular Intervention business, particularly the former BIOTRONIK assets, is a significant driver, with management anticipating the combined Interventional business to generate over $800 million in annual revenues.
Competitive Landscape
Pro stress-test →Teleflex competes in the medical device sector against larger diversified healthcare companies and specialized device manufacturers. Key competitors include Boston Scientific (interventional and vascular), Edwards Lifesciences (cardiac devices), and various regional medical device suppliers. The company's diversified portfolio across vascular access, interventional, anesthesia, and surgical segments positions it against both focused competitors and larger integrated medical device companies.
Industry Context
Teleflex Incorporated operates in Medical Devices - Surgical & Critical Care.
Key facts
Founded: 1943 · Headquarters: Wayne, US · Employees: 14,100 · Revenue: $3.27B · Market cap: $4.69B